Oura Health, the Finland-based maker of the popular Oura Ring biometric wearable, has confidentially filed its initial public offering paperwork with the U.S. Securities and Exchange Commission, the company confirmed. The filing, submitted on Thursday, marks a formal step toward a public listing, though Oura has not yet determined the number of shares it will offer or the proposed price range.

The Filing Details

The confidential submission was made directly by the company, which confirmed the move without disclosing further financial specifics. according to reports, Oura had been interviewing banks to advise on its IPO as recently as March, signalling that preparations have been underway for several months. Confidential filings of this kind are permitted under U.S. JOBS Act provisions, allowing companies to submit initial paperwork to the SEC while keeping financial details private until closer to the public offering.

What Oura Makes

Oura Health, founded in 2013 in Finland, develops the Oura Ring — a finger-worn device that tracks sleep quality, heart rate variability, body temperature, and daily activity, generating personalised recovery and readiness scores for users. The product has attracted a broad consumer following and partnerships with professional sports organisations for athlete performance monitoring. The company expanded its product line with a third-generation ring in 2021, broadening its appeal in the competitive wearable health market.

Why It Matters

The move positions Oura among a wave of digital health and wearable technology companies pursuing public listings as consumer adoption of personal biometric tracking has accelerated since 2020. A successful listing would give the company access to capital to scale sensor manufacturing, cloud analytics infrastructure, and international distribution. Hardware-focused digital health firms have historically used IPO proceeds to fund the kind of global expansion that is difficult to sustain on private funding alone.

Competitive Backdrop

The wearable health space has grown increasingly crowded, with major technology companies and dedicated hardware makers competing for users' wrists and fingers. Oura's ring form factor differentiates it from dominant smartwatch players, but the company will face investor scrutiny over user retention, subscription revenue, and the long-term defensibility of its sensor technology. The public markets will also assess how Oura plans to compete as larger platforms integrate similar biometric features natively into their devices.

What's Next

The company must still determine share count and price range before proceeding to a public roadshow, meaning the timeline for an actual listing remains open. Investors and industry observers will watch for the prospectus disclosure, which will reveal revenue figures, user growth, and the names of underwriting banks for the first time. The outcome of this offering could set a benchmark for other digital health hardware companies eyeing the public markets in the near term.